全球再生醫療市場:各產品、治療方法、用途、地區 - 成長，趨勢，預測(2018年∼2023年)
Regenerative Medicine Market - Growth, Trends, and Forecast (2019 - 2024)
|出版商||Mordor Intelligence LLP||商品編碼||613022|
|出版日期||內容資訊||英文 117 Pages
|全球再生醫療市場:各產品、治療方法、用途、地區 - 成長，趨勢，預測(2018年∼2023年) Regenerative Medicine Market - Growth, Trends, and Forecast (2019 - 2024)|
|出版日期: 2019年02月01日||內容資訊: 英文 117 Pages||
The key factors propelling the growth of the global regenerative medicine market are the increasing adoption of stem cell technologies, gene therapies, and tissue engineering, and the technological advancements in regenerative medicine.
Stem cell technology is a rapidly developing technology that plays a major role in regenerative medicine, as it also serves the disciplines of tissue engineering, developmental cell biology, cellular therapeutics, gene therapy, chemical biology, and nanotechnology. Stem cells offer the possibility of replacing the cells and tissues to treat various conditions including spinal cord injury, arthritis, and Parkinson's disease, among others. The applications of stem cell technologies in the treatment of diseases have ultimately increased the overall adoption rate of these technologies across the world.
The market is found experiencing the major technological advancements in biologics, biomaterials, stem cell technology, and tissue engineering, thus contributing to the market growth. There are also various recent advancements in regenerative medicine, including the regenerated tracheas for transplant, 3D bioprinting, stem cell treatments for vision loss, and stem cell treatments for heart repair.
The current market is also witnessing extensive R&D activities. Apart from the R&D activities being conducted by private players, there is significant involvement of academic institutions for conducting various research. Therefore, in the future, several new biotech and medtech companies are expected to come up, as the result of the current R&D endeavors across the world.
As per the scope of the report, regenerative medicines are used to repair, replace, and regenerate the tissues and organs affected by injury, disease, or the natural aging process. These medicines restore the functionality of cells and tissues and are used in several degenerative disorders, such as dermatology, neurodegenerative diseases, cardiovascular, and orthopedic applications.
Dermatology is the Segment by Application that is Expected to be the Largest During the Forecast Period
Dermatology is estimated to have the largest share in revenue generation, and this high contribution is attributive to the presence of easy grafting techniques for dermatological wounds and diseases. Skin, being an organ with great cell replication characteristics, provides various types of stem cells from its different layers. Therefore, there are a broad range of products present, from patches to cure small injuries to matrix and grafts for chronic wounds and burns. Thus, the segment is expected to continue to dominate the market through to the forecast period.
The increasing number of accidents and bone defects is also expected to drive the regenerative medicine market. There are also several research studies that are being conducted on tissue engineering for the development of bone graft substitutes, with the help of regenerative medicine. So, with the new advances in bone graft, the market is expected to grow over the forecast period.
North America Holds the Largest Share and is Expected to Follow the Same Trend Over the Forecast Period
North America is estimated to have the largest share, in terms of revenue, owing to the presence of major players and rapid advances in technology, along with high investments in stem cell and oncology research. There is also an increasing prevalence of diseases, such as cancer and diabetes, which can now be cured by various stem cell therapies. Additionally, the awareness regarding the available stem cell procedures and therapies among people is rising, which in turn, is increasing the demand for the overall market.
The global regenerative medicine market is highly competitive and fragmented. The small-scale companies are also merging with large companies to develop tissue models for research and therapeutic purposes. Thus, companies are making considerable investments in novel technologies, thus driving the market.